⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5967513 | 0.71 | — | — | |
| SCHEMBL215660 | 0.71 | — | — | |
| SCHEMBL2712929 | 0.69 | — | — | |
| SCHEMBL23631449 | 0.67 | — | — | |
| SCHEMBL842845 | 0.67 | — | — | |
| SCHEMBL778513 | 0.67 | — | — | |
| SCHEMBL5530412 | 0.67 | — | — | |
| SCHEMBL2373795 | 0.67 | — | — | |
| SCHEMBL10596477 | 0.67 | — | — | |
| SCHEMBL15664663 | 0.67 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 182 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-112812072-B | Triazole derivative containing deuterium and alkenyl, preparation method and application | 山东师范大学 | 2022-07-22 | — | — | CN | claimed |
| CN-112812072-A | Triazole derivative containing deuterium and alkenyl, preparation method and application | 山东师范大学 | 2021-05-18 | — | — | CN | claimed |
| CN-109796490-A | A kind of preparation method of organic phosphine fire retardant 1- hydroxyl phosphinate | 泉州师范学院 | 2019-05-24 | — | — | CN | claimed |
| US-20160143870-A1 | IDO INHIBITORS | BRISTOL MYERS SQUIBB CO (US) | 2016-05-26 | — | — | US | claimed |
| EP-3019488-A1 | IDO INHIBITORS | Bristol-Myers Squibb Company (US) | 2016-05-18 | — | — | EP | claimed |
| CN-105517999-A | Ido inhibitors | BRISTOL MYERS SQUIBB CO | 2016-04-20 | — | — | CN | claimed |
| US-20150246136-A1 | NOVEL BINDER-DRUG CONJUGATES (ADCs) AND USE OF SAME | SEATTLE GENETICS, INC. (US) | 2015-09-03 | — | — | US | claimed |
| US-20150023989-A1 | NEW ANTIBODY DRUG CONJUGATES (ADCS) AND THE USE THEREOF | SEATTLE GENETICS, INC. | 2015-01-22 | — | — | US | claimed |
| WO-2015006520-A1 | IDO INHIBITORS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2015-01-15 | — | — | WO | claimed |
| CN-104254342-A | FGRF antibody drug conjugates (ADCs) and the use thereof | SEATTLE GENETICS INC | 2014-12-31 | — | — | CN | claimed |
| CN-1950375-A | Glucocorticoid receptor modulator compounds and methods- utility | LIGAND PHARM INC (US) | 2007-04-18 | — | — | CN | claimed |
| EP-1718653-A1 | GLUCOCORTICOID RECEPTOR MODULATOR COMPOUNDS AND METHODS- UTILITY | Ligand Pharmaceuticals Inc. (US) | 2006-11-08 | — | — | EP | claimed |
| WO-2005082909-A1 | GLUCOCORTICOID RECEPTOR MODULATOR COMPOUNDS AND METHODS- UTILITY | LIGAND PHARMACEUTICALS INCORPORATED (US) | 2005-09-09 | — | — | WO | claimed |
| US-5665778-A | Ceramides, process for their preparation and their applications in cosmetics and in dermopharmacy | L'OREAL (FR) | 1997-09-09 | — | — | US | claimed |
| EP-0647617-B1 | Ceramides, process for their preparation and their cosmetic uses | OREAL (FR) | 1997-07-23 | — | — | EP | claimed |
| EP-0404190-B1 | Condensed heterocyclic compounds, their production and use | TAKEDA CHEMICAL INDUSTRIES LTD (JP) | 1995-10-25 | — | — | EP | claimed |
| US-5270308-A | Hypotensives | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1993-12-14 | — | — | US | claimed |
| CN-1060467-A | 1,3-benzoxazine derivatives, its production method and purposes | TAKEDA CHEMICAL INDUSTRIES LTD (JP) | 1992-04-22 | — | — | CN | claimed |
| EP-0477789-A1 | 1,3-Benzoxazine derivatives, their production and use | Takeda Chemical Industries, Ltd. (JP) | 1992-04-01 | — | — | EP | claimed |
| US-5098931-A | Anticholesterol agents or antilipemic agents | MERCK & CO., INC. (US) | 1992-03-24 | — | — | US | claimed |